Skip to main content

Gout

      RT @RichardPAConway: Is diet important in gout control? #ACR20 @rheumnow

      Richard Conway RichardPAConway

      4 years 11 months ago
      Is diet important in gout control? #ACR20 @rheumnow
      RT @DrPetryna: @RheumNow #acr20 abs0665 claim based database stdy of pegloticase/immunomodulation coadministration trend

      Olga Petryna DrPetryna

      4 years 11 months ago
      @RheumNow #acr20 abs0665 claim based database stdy of pegloticase/immunomodulation coadministration trends: use of co-immunomodulation ⬆️ from 1.2%-3.9% 2015- 2018 to 15.0% in 2019. 86%start immunomodulator within 30 days of first peg infusion. MTX most commonly used
      ACR20 convergence highlights a shift in gout management and uric acid lowering therapy (ULT). The new biologics pegdriticase and pegloticase are associated with risk of immunogenicity and loss of biological effects.
      RT @DrPetryna: @RheumNow #acr20 abs0690 ph2a trial: potent reduction of sUA w/URAT1 inhibitor AA882. 100% of pts sUA lev

      Olga Petryna DrPetryna

      4 years 11 months ago
      @RheumNow #acr20 abs0690 ph2a trial: potent reduction of sUA w/URAT1 inhibitor AA882. 100% of pts sUA levels < 6 mg/dL &63% pts < 5 mg/dL compared to febuxostat 50% & 13% respectively. Even more remarkable reduction w/ AA882+febuxostat. Mild to moderate SEs. https://t.co/XrDJXEoC1j
      RT @DrPetryna: @RheumNow #acr20 abs0600 a case control stdy of 545 CHF exacerbate admissions: pts w/gout flares median L

      Olga Petryna DrPetryna

      4 years 11 months ago
      @RheumNow #acr20 abs0600 a case control stdy of 545 CHF exacerbate admissions: pts w/gout flares median LoS 10 d vs 6 d w/out flare or gout at all. log LoS w gout flare 2.41 ± 0.96 vs 1.77 ± 0.90 w/out, p < 0.0001. Prevention of gout flares in CHF pts of essence #ACRbest https://t.co/8xiHHYxvsC
      RheumNow’s expanded coverage of the #ACR20 Annual meeting is sponsored in part by @bmsnews, @HorizonNews, @SanofiGenzy

      Dr. John Cush RheumNow

      4 years 11 months ago
      RheumNow’s expanded coverage of the #ACR20 Annual meeting is sponsored in part by @bmsnews, @HorizonNews, @SanofiGenzyme, @Novartis. All content chosen by RheumNow and its Faculty.
      RT @DrPetryna: @RheumNow #acr20 abs 0649 PROTECT trial of pegloticase in 7 kidney transplant pts w/uncontrolled gout: 2-

      Olga Petryna DrPetryna

      4 years 11 months ago
      @RheumNow #acr20 abs 0649 PROTECT trial of pegloticase in 7 kidney transplant pts w/uncontrolled gout: 2-12 infusions, 2+immunosuppressants on board for transplant care. No change in eGFR, HAQ pain ⬇️by 33.8 at wk20. Alb/cr improved by >35%in 2pts. sUA< 1 mg/dL, no serious AEs https://t.co/f4tnFjMTe8
      RT @DrPetryna: How often, if ever, do you use DECT to diagnose gout?

      Olga Petryna DrPetryna

      4 years 11 months ago
      How often, if ever, do you use DECT to diagnose gout?
      RT @RichardPAConway: Dr Peral reports on intracellular crystal containing vacuoles in gout and CPP arthritis. Crystal co

      Richard Conway RichardPAConway

      4 years 11 months ago
      Dr Peral reports on intracellular crystal containing vacuoles in gout and CPP arthritis. Crystal containing vacuoles only seen in CPP arthritis. @rheumnow #ACR20 Abstr#666 https://t.co/ITQMXhjQt0
      RT @RichardPAConway: Dr Vargas-Santos reported on risk of gout with SGLT2-inhibitors using THIN database. Canagliflozin

      Richard Conway RichardPAConway

      4 years 11 months ago
      Dr Vargas-Santos reported on risk of gout with SGLT2-inhibitors using THIN database. Canagliflozin shown in prior RCT to reduce gout risk. Here dapagliflozin and empagliflozin showed even stronger effect @rheumnow #ACR20 Abstr#660 https://t.co/MTjByMmHo7
      RT @RichardPAConway: Dr Minalyan and colleagues report rates of gout flare following hospital admission of patients pres

      Richard Conway RichardPAConway

      4 years 11 months ago
      Dr Minalyan and colleagues report rates of gout flare following hospital admission of patients prescribed allopurinol. Gout flare 14 times more likely if allopurinol stopped or omitted. @rheumnow #ACR20 Abstr#688 https://t.co/x3eyX1PLFB
      RT @RichardPAConway: Dr McCormick reports sequential patterns of gout flare from the Boston Online Gout Study. Second at

      Richard Conway RichardPAConway

      4 years 11 months ago
      Dr McCormick reports sequential patterns of gout flare from the Boston Online Gout Study. Second attack most likely to affect ipsilateral same joint, and second most likely contralateral same joint. @rheumnow #ACR20 Abstr#672 https://t.co/2AAMvcOCk8
      Get the highlights on the opening day of #ACR20. Listen in to faculty reports and overviews. Follow the link below or

      Dr. John Cush RheumNow

      4 years 11 months ago
      Get the highlights on the opening day of #ACR20. Listen in to faculty reports and overviews. Follow the link below or find us on Apple podcasts under RheumNow Podcast. https://t.co/qDQzCAHsHi https://t.co/9nM19ZdHQQ
      RT @RichardPAConway: Dr Murdoch and colleagues report “An Apple Pie a Day Does Not Keep the Doctor Away”. An analysi

      Richard Conway RichardPAConway

      4 years 11 months ago
      Dr Murdoch and colleagues report “An Apple Pie a Day Does Not Keep the Doctor Away”. An analysis of the negative depictions of gout in tv and film and how this may affect our care. @rheumnow #ACR20 Abstr#646 https://t.co/BBW0Fd5kHE
      Advanced Imaging for Crystal Arthritis: Which Test is Best? Dr. Nicola Dalbeth

      Dr. Nicola Dalbeth of Aukland, New Zealand examines abstracts #0647 and #1542 involving imaging studies for crystal arthritis at ACR 2020.

      ×